Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

Clinical trial NCT05875961 · COMPLETED

Trial details

NCT number: NCT05875961
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza, Human Infections Respiratory Tract Infections Virus Diseases Infection Viral

Start date: 2023-06-15
Primary completion: 2024-11-15
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.